Evidence map›Paper›PMID 41148055›Full record

ArticleCurrent protocols2025

Methodological Considerations in Saliva-Based Biomarker Research: Addressing Patient-Specific Variability in Translational Research Protocols.

Shirleen Xu, Abdul Nabiel Mumuni, Ralph Thadeus S Tuason, Katherine A Maki

Abstract read
In one paragraph

Article in Current protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shirleen XuTranslational Biobehavioral and Health Promotion Branch, Clinical Center, National Institutes of Health, Bethesda, Maryland.
Abdul Nabiel MumuniTranslational Biobehavioral and Health Promotion Branch, Clinical Center, National Institutes of Health, Bethesda, Maryland.
Ralph Thadeus S TuasonTranslational Biobehavioral and Health Promotion Branch, Clinical Center, National Institutes of Health, Bethesda, Maryland.
Katherine A MakiTranslational Biobehavioral and Health Promotion Branch, Clinical Center, National Institutes of Health, Bethesda, Maryland.ORCID https://orcid.org/0000-0003-4578-960X

Funding

Intramural NIH HHS Z99 CL999999
6 · The paper itself

Abstract

Saliva plays a central role in maintaining oral homeostasis by supporting tooth integrity, providing lubrication, and functioning as an antimicrobial wash. It also serves as a transport medium, carrying byproducts and signaling metabolites across oral niches and through the gastrointestinal tract. Because of its biological relevance and ease of collection, saliva is increasingly used as a noninvasive biospecimen for measuring cortisol, cytokines, and metabolites. However, the validity and reliability of saliva as an indicator of local and systemic biomarkers remain under investigation across diverse populations and research applications. Specific patient populations (e.g., individuals with alcohol use disorder) are particularly vulnerable to oral health problems, periodontal disease, and high rates of nicotine use. In addition to behavioral factors (e.g., food, drink, toothbrushing, and mouthwash), patient-specific variables can introduce contaminants such as nicotine and blood into saliva, potentially compromising the accurate measurement of analytes of interest. Protocols that account for possible contaminants are essential to ensure rigorous and reproducible biomarker research. Assessing factors such as pH, flow rate, and visible discoloration helps reduce limitations in analysis and improves interpretation in studies that include heterogeneous populations and health behaviors. Yet, the literature provides limited guidance on standardized methods for saliva collection, processing, and measurement of patient-specific confounders alongside analytes of interest. This protocol addresses these gaps by presenting detailed methodologies for saliva collection and processing, assessment of quantitative and qualitative salivary properties, and quantification of patient-specific modifiers. These approaches support reproducible diagnostics and have applications in populations with high rates of smoking, periodontal disease, and alcohol use. Published 2025. This article is a U.S. Government work and is in the public domain in the USA. Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Saliva collection by the passive drool method Basic Protocol 2: Processing, storage, and characterization of saliva (visual assessment scale, pH, and flow rate) Basic Protocol 3: Quantification of cotinine in salivary supernatant Basic Protocol 4: Quantification of transferrin in salivary supernatant.

Indexed as

SalivaSpecimen HandlingTranslational Research, BiomedicalBiomarkersCotinineHumansTransferrinBiomarkersCotinineTransferrinoral healthperiodontal diseasessalivasalivary biomarkerssmoking

Identifiers

PMID41148055
PMCPMC12560811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.